Back to results
US 6,599,522 B2Granted
Triglyceride reducing agent
OwnerLakshminarayan Rao V. Mokshagundaminventor
Life of this patent
Estimating the term…
Abstract
The use of vanillin as a hypolipidemic—a hypotriglyceridemic pharmaceutical agent over a wide range of concentration in the treatment of diabetes (type-2), cardiovascular disturbances, and obesity. Vanillin is also used as a food additive for preventing the development of such pathological conditions, particularly in young people.
Claims12
A composition for the reduction of triglycerides and total cholesterol in a hyperlipidemic patient, comprising:
- an effective amount of vanillin for reducing triglycerides and total cholesterol;
- an effective amount of ascorbic acid for protecting an aldehyde group in the vanillin;
- and
- an effective amount of ethylenediaminetetraacetic acid for preserving the ascorbic acid in a reduced state.
1 more element
A gelatin capsule for the reduction of triglycerides and total cholesterol in a hyperlipidemic patient, comprising:
- 20 to 2,000 milligrams of vanillin;
- 10 to 15 milligrams of ascorbic acid;
- and
- 5 to 10 milligrams of ethylenediaminetetraacetic acid.
1 more element
Dependencies are inferred from the claim text.